Intrepid Family Office’s Organogenesis Holdings ORGO Stock Holding History

Intrepid Family Office’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$174K	Sell	73,580 -26,420	-26%	-$91.5K	0.14%	34
2025 Q4	$518K	Buy	100,000 +19,900	+25%	+$96.4K	0.45%	31
2025 Q3	$338K	Sell	80,100 -29,900	-27%	-$139K	0.28%	30
2025 Q2	$403K	Buy	110,000 +10,000	+10%	+$37.3K	0.33%	33
2025 Q1	$432K	Sell	100,000 -5,000	-5%	-$20.2K	0.61%	26
2024 Q4	$336K	Buy	+105,000	New	+$352K	0.35%	29
2023 Q3	$318K	Sell	100,000 -10,000	-9%	-$31.8K	0.51%	26
2023 Q2	$365K	Buy	110,000 +70,000	+175%	+$207K	0.7%	24
2023 Q1	$85.2K	Hold	40,000	–	–	0.19%	23
2022 Q4	$108K	Buy	40,000 +5,000	+14%	+$14.6K	0.27%	22
2022 Q3	$113K	Buy	+35,000	New	+$158K	0.34%	19

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Intrepid Family Office's ORGO Position: Q1 2026 in Review

Intrepid Family Office reduced its Organogenesis Holdings (ORGO) stake by 26% in Q1 2026, selling an estimated $91.5K and leaving 73,580 shares worth $174K. The position accounts for 0.14% of the portfolio, ranked #34.

Intrepid Family Office first reported a position in ORGO in Q3 2022 and has held it in 11 quarters since. The position peaked at $518K in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Intrepid Family Office held 73,580 shares of Organogenesis Holdings worth $174K as of Q1 2026.
Intrepid Family Office sold 26,420 Organogenesis Holdings shares in Q1 2026, an estimated $91.5K.
Organogenesis Holdings made up 0.14% of Intrepid Family Office's portfolio in Q1 2026, its #34 holding.
Intrepid Family Office first reported a position in Organogenesis Holdings in Q3 2022 and has held it in 11 quarters since.
Intrepid Family Office's Organogenesis Holdings position peaked at $518K in Q4 2025.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Intrepid Family Office's 13F filing for Q1 2026, filed 15 May 2026.